Vicki L. Sato is Director at Vir Biotechnology, Inc. (VIR). They have made 38 open-market trades across 3 companies since 2009, most recently 2026-05-01.
CIK 0001197020
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 38 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIR | 1,078,391 | $10.8M |
| PKI | 29,970 | $3.5M |
| DNLI | 107,976 | $1.9M |
| BWA | 19,823 | $1.2M |
| ALLO | 162,575 | $213K |
| INFI | 11,051 | $494 |
| Total | $17.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL · 10b5-1 | 2026-05-01 | 2026-05-04 | $10.05 | $221K | -12.0% | -15.2% | -13.9% |
| VIR | SELL · 10b5-1 | 2026-04-01 | 2026-04-02 | $9.07 | $200K | +17.3% | +14.1% | +7.2% |
| VIR | SELL | 2026-03-02 | 2026-03-03 | $9.51 | $209K | +0.7% | -1.5% | -1.8% |
| VIR | SELL | 2026-02-24 | 2026-02-26 | $9.75 | $413K | +6.4% | -8.9% | -2.2% |
| VIR | SELL · 10b5-1 | 2026-02-02 | 2026-02-03 | $7.71 | $170K | -2.2% | +19.1% | +33.2% |
| VIR | SELL · 10b5-1 | 2026-01-02 | 2026-01-05 | $5.93 | $130K | +7.2% | +29.6% | +56.6% |
| VIR | SELL · 10b5-1 | 2025-12-01 | 2025-12-02 | $6.00 | $132K | +18.6% | +5.3% | +65.6% |
| VIR | SELL · 10b5-1 | 2025-11-03 | 2025-11-04 | $5.64 | $124K | +9.1% | +31.4% | +49.4% |
| VIR | SELL · 10b5-1 | 2025-10-01 | 2025-10-02 | $5.84 | $128K | +0.2% | -1.9% | +5.6% |
| VIR | SELL · 10b5-1 | 2025-09-02 | 2025-09-03 | $4.99 | $110K | -13.2% | +3.8% | +2.0% |
| VIR | SELL · 10b5-1 | 2025-08-01 | 2025-08-04 | $4.99 | $110K | -13.1% | +7.8% | +9.6% |
| VIR | SELL · 10b5-1 | 2025-07-01 | 2025-07-02 | $5.10 | $224K | -2.0% | -7.0% | +5.5% |
| VIR | SELL · 10b5-1 | 2025-01-08 | 2025-01-08 | $12.52 | $274K | -17.0% | -22.4% | -59.1% |
| DNLI | SELL · 10b5-1 | 2025-01-02 | 2025-01-03 | $20.91 | $129K | +2.7% | +3.5% | -39.4% |
| DNLI | SELL · 10b5-1 | 2024-11-07 | 2024-11-12 | $30.00 | $31K | -17.8% | -21.9% | -30.5% |
| DNLI | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $27.07 | $167K | -13.6% | -19.5% | -24.6% |
| DNLI | SELL · 10b5-1 | 2024-09-13 | 2024-09-16 | $30.00 | $31K | -4.4% | -9.6% | -23.9% |
| DNLI | SELL · 10b5-1 | 2024-09-03 | 2024-09-04 | $25.00 | $151K | +20.1% | +13.4% | -5.4% |
| DNLI | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $22.13 | $134K | +13.7% | +3.8% | +36.1% |
| DNLI | SELL · 10b5-1 | 2024-05-15 | 2024-05-17 | $20.39 | $34K | -10.1% | -0.3% | +15.2% |
| DNLI | SELL · 10b5-1 | 2024-04-15 | 2024-04-17 | $18.29 | $30K | -6.7% | +22.7% | +43.2% |
| DNLI | SELL · 10b5-1 | 2024-03-15 | 2024-03-19 | $20.10 | $33K | +1.1% | -18.4% | +0.7% |
| DNLI | SELL · 10b5-1 | 2024-02-15 | 2024-02-20 | $18.37 | $31K | +27.4% | +28.2% | +22.9% |
| DNLI | SELL · 10b5-1 | 2024-01-16 | 2024-01-18 | $18.42 | $31K | +0.4% | -0.7% | +1.0% |
| DNLI | SELL · 10b5-1 | 2023-12-15 | 2023-12-18 | $23.39 | $39K | -3.4% | -22.9% | -9.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.